Question 1

Does Marshall Wace own KLRS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Marshall Wace holds 139,201 shares of KLRS (Kalaris Therapeutics), worth $566,549.

Question 2

How many shares of KLRS does Marshall Wace own?

Accepted Answer

As of its Q2 2026 13F, Marshall Wace holds 139,201 shares of KLRS (Kalaris Therapeutics).

Question 3

What is Marshall Wace's KLRS position worth?

Accepted Answer

As of its Q2 2026 13F, Marshall Wace's KLRS position is worth $566,549.

Question 4

Is Marshall Wace buying or selling KLRS?

Accepted Answer

In Q2 2026, Marshall Wace increased its KLRS position by 71,322 shares (+105.1%).

Question 5

When did Marshall Wace first buy KLRS?

Accepted Answer

Marshall Wace already held KLRS in its Q1 2025 13F, the earliest on record, and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	139,201	+105.1%	$566,549	0.0%	$4.07	39
2026-Q1	Decreased	67,879	-6.9%	$391,662	0.0%	$9.42	0
2025-Q4	Increased	72,876	+416.3%	$615,074	0.0%	$8.38	39
2025-Q3	Unchanged	14,115	0.0%	$81,585	0.0%	$6.35	0
2025-Q2	Unchanged	14,115	0.0%	$37,687	0.0%	$2.62	0
2025-Q1	New	14,115	-	$113,343	0.0%	$8.60	30

KLRS6 quarters

KLRS
6 quarters